Jerusalem, Jerusalem District, Israel HBL Hadasit Bio Holdings is the famous Corporate Investor, which was founded in 2005. The leading representative office of defined Corporate Investor is situated in the Jerusalem. The venture was found in Asia in Israel.
When the investment is from HBL Hadasit Bio Holdings the average startup value is 50-100 millions dollars. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2009. Considering the real fund results, this Corporate Investor is 6 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this HBL Hadasit Bio Holdings performs on 15 percentage points less the average number of lead investments. The increased amount of exits for fund were in 2019. Deals in the range of 1 - 5 millions dollars are the general things for fund.
Among the most successful fund investment fields, there are Health Care, Pharmaceutical. For fund there is a match between the location of its establishment and the land of its numerous investments - Israel. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight ProtAb, KAHR medical, KAHR medical.
This organization was formed by Rafi Hofstein.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the HBL Hadasit Bio Holdings, startups are often financed by Sanofi Aventis, Shai Novik, Korea Investment Partners. The meaningful sponsors for the fund in investment in the same round are Sanofi Aventis, Korea Investment Partners, Pontifax. In the next rounds fund is usually obtained by Korea Investment Partners, Sanofi Aventis, Mirae Asset Venture Investment.
Related Funds
Funds with similar focus
| Fund Name | Location |
| AIB Equity | County Dublin, Dublin, Ireland |
| Asgent | - |
| Ballpark Ventures | Cheltenham, Gloucestershire, United Kingdom |
| GCI Capital Co., Ltd. | Japan, Tokyo |
| Hunch Ventures | Delhi, India, New Delhi |
| Internet Attitude | Belgium, Liege, Waremme |
| Oreilly AlphaTech Ventures | California, San Francisco, United States |
| Peregrine Systems | Minneapolis, Minnesota, United States |
| Preview Ventures | - |
| Qiuling Capital | Beijing, Beijing, China |
| RNT Capital | - |
| Saugatuck Capital | Connecticut, United States, Wilton |
| Sino-Century International Investment | Beijing, China, Haidian |
| The Amherst Fund | Ann Arbor, Michigan, United States |
| The Lind Partners | New York, New York, United States |
| Tippet Venture Partners | California, Palo Alto, United States |
| UPMC | Pennsylvania, Pittsburgh, United States |
| USAID East Africa Trade and Investment Hub | - |
| Xinmei Touzi | - |
| Yaohong Chuangtou | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Enlivex Therapeutics | $8M | 19 Sep 2017 | Israel, North District, Israel | ||
ProtAb | $4M | 23 Apr 2010 | Jerusalem, Jerusalem District, Israel | ||
KAHR medical | $1M | 01 Dec 2009 | Jerusalem, Jerusalem District, Israel |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Enlivex Therapeutics | $8M | 19 Sep 2017 | Israel, North District, Israel | ||
ProtAb | $4M | 23 Apr 2010 | Jerusalem, Jerusalem District, Israel | ||
KAHR medical | $1M | 01 Dec 2009 | Jerusalem, Jerusalem District, Israel |
